1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Japan Pharmacovigilance Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Japan Pharmacovigilance Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)
6 Japan Pharmacovigilance Market - Breakup by Service Provider
6.1 In-house
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Forecast (2025-2033)
6.2 Contract Outsourcing
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Forecast (2025-2033)
7 Japan Pharmacovigilance Market - Breakup by Product Life Cycle
7.1 Pre-clinical
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Forecast (2025-2033)
7.2 Phase I
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Forecast (2025-2033)
7.3 Phase II
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2019-2024)
7.3.3 Market Forecast (2025-2033)
7.4 Phase III
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2019-2024)
7.4.3 Market Forecast (2025-2033)
7.5 Phase IV
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2019-2024)
7.5.3 Market Forecast (2025-2033)
8 Japan Pharmacovigilance Market - Breakup by Type
8.1 Spontaneous Reporting
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Forecast (2025-2033)
8.2 Intensified ADR Reporting
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Forecast (2025-2033)
8.3 Targeted Spontaneous Reporting
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2019-2024)
8.3.3 Market Forecast (2025-2033)
8.4 Cohort Event Monitoring
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2019-2024)
8.4.3 Market Forecast (2025-2033)
8.5 EHR Mining
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2019-2024)
8.5.3 Market Forecast (2025-2033)
9 Japan Pharmacovigilance Market - Breakup by Process Flow
9.1 Case Data Management
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2019-2024)
9.1.3 Market Segmentation
9.1.3.1 Case Logging
9.1.3.2 Case Data Analysis
9.1.3.3 Medical Reviewing and Reporting
9.1.4 Market Forecast (2025-2033)
9.2 Signal Detection
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2019-2024)
9.2.3 Market Segmentation
9.2.3.1 Adverse Event Logging
9.2.3.2 Adverse Event Analysis
9.2.3.3 Adverse Event Review and Reporting
9.2.4 Market Forecast (2025-2033)
9.3 Risk Management System
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2019-2024)
9.3.3 Market Segmentation
9.3.3.1 Risk Evaluation System
9.3.3.2 Risk Mitigation System
9.3.4 Market Forecast (2025-2033)
10 Japan Pharmacovigilance Market - Breakup by Therapeutic Area
10.1 Oncology
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2019-2024)
10.1.3 Market Forecast (2025-2033)
10.2 Neurology
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2019-2024)
10.2.3 Market Forecast (2025-2033)
10.3 Cardiology
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2019-2024)
10.3.3 Market Forecast (2025-2033)
10.4 Respiratory Systems
10.4.1 Overview
10.4.2 Historical and Current Market Trends (2019-2024)
10.4.3 Market Forecast (2025-2033)
10.5 Others
10.5.1 Historical and Current Market Trends (2019-2024)
10.5.2 Market Forecast (2025-2033)
11 Japan Pharmacovigilance Market - Breakup by End Use
11.1 Pharmaceuticals Companies
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2019-2024)
11.1.3 Market Forecast (2025-2033)
11.2 Biotechnology Companies
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2019-2024)
11.2.3 Market Forecast (2025-2033)
11.3 Medical Device Companies
11.3.1 Overview
11.3.2 Historical and Current Market Trends (2019-2024)
11.3.3 Market Forecast (2025-2033)
11.4 Others
11.4.1 Historical and Current Market Trends (2019-2024)
11.4.2 Market Forecast (2025-2033)
12 Japan Pharmacovigilance Market – Breakup by Region
12.1 Kanto Region
12.1.1 Overview
12.1.2 Historical and Current Market Trends (2019-2024)
12.1.3 Market Breakup by Service Provider
12.1.4 Market Breakup by Product Life Cycle
12.1.5 Market Breakup by Type
12.1.6 Market Breakup by Process Flow
12.1.7 Market Breakup by Therapeutic Area
12.1.8 Market Breakup by End Use
12.1.9 Key Players
12.1.10 Market Forecast (2025-2033)
12.2 Kansai/Kinki Region
12.2.1 Overview
12.2.2 Historical and Current Market Trends (2019-2024)
12.2.3 Market Breakup by Service Provider
12.2.4 Market Breakup by Product Life Cycle
12.2.5 Market Breakup by Type
12.2.6 Market Breakup by Process Flow
12.2.7 Market Breakup by Therapeutic Area
12.2.8 Market Breakup by End Use
12.2.9 Key Players
12.2.10 Market Forecast (2025-2033)
12.3 Central/ Chubu Region
12.3.1 Overview
12.3.2 Historical and Current Market Trends (2019-2024)
12.3.3 Market Breakup by Service Provider
12.3.4 Market Breakup by Product Life Cycle
12.3.5 Market Breakup by Type
12.3.6 Market Breakup by Process Flow
12.3.7 Market Breakup by Therapeutic Area
12.3.8 Market Breakup by End Use
12.3.9 Key Players
12.3.10 Market Forecast (2025-2033)
12.4 Kyushu-Okinawa Region
12.4.1 Overview
12.4.2 Historical and Current Market Trends (2019-2024)
12.4.3 Market Breakup by Service Provider
12.4.4 Market Breakup by Product Life Cycle
12.4.5 Market Breakup by Type
12.4.6 Market Breakup by Process Flow
12.4.7 Market Breakup by Therapeutic Area
12.4.8 Market Breakup by End Use
12.4.9 Key Players
12.4.10 Market Forecast (2025-2033)
12.5 Tohoku Region
12.5.1 Overview
12.5.2 Historical and Current Market Trends (2019-2024)
12.5.3 Market Breakup by Service Provider
12.5.4 Market Breakup by Product Life Cycle
12.5.5 Market Breakup by Type
12.5.6 Market Breakup by Process Flow
12.5.7 Market Breakup by Therapeutic Area
12.5.8 Market Breakup by End Use
12.5.9 Key Players
12.5.10 Market Forecast (2025-2033)
12.6 Chugoku Region
12.6.1 Overview
12.6.2 Historical and Current Market Trends (2019-2024)
12.6.3 Market Breakup by Service Provider
12.6.4 Market Breakup by Product Life Cycle
12.6.5 Market Breakup by Type
12.6.6 Market Breakup by Process Flow
12.6.7 Market Breakup by Therapeutic Area
12.6.8 Market Breakup by End Use
12.6.9 Key Players
12.6.10 Market Forecast (2025-2033)
12.7 Hokkaido Region
12.7.1 Overview
12.7.2 Historical and Current Market Trends (2019-2024)
12.7.3 Market Breakup by Service Provider
12.7.4 Market Breakup by Product Life Cycle
12.7.5 Market Breakup by Type
12.7.6 Market Breakup by Process Flow
12.7.7 Market Breakup by Therapeutic Area
12.7.8 Market Breakup by End Use
12.7.9 Key Players
12.7.10 Market Forecast (2025-2033)
12.8 Shikoku Region
12.8.1 Overview
12.8.2 Historical and Current Market Trends (2019-2024)
12.8.3 Market Breakup by Service Provider
12.8.4 Market Breakup by Product Life Cycle
12.8.5 Market Breakup by Type
12.8.6 Market Breakup by Process Flow
12.8.7 Market Breakup by Therapeutic Area
12.8.8 Market Breakup by End Use
12.8.9 Key Players
12.8.10 Market Forecast (2025-2033)
13 Japan Pharmacovigilance Market – Competitive Landscape
13.1 Overview
13.2 Market Structure
13.3 Market Player Positioning
13.4 Top Winning Strategies
13.5 Competitive Dashboard
13.6 Company Evaluation Quadrant
14 Profiles of Key Players
14.1 Company A
14.1.1 Business Overview
14.1.2 Services Offered
14.1.3 Business Strategies
14.1.4 SWOT Analysis
14.1.5 Major News and Events
14.2 Company B
14.2.1 Business Overview
14.2.2 Services Offered
14.2.3 Business Strategies
14.2.4 SWOT Analysis
14.2.5 Major News and Events
14.3 Company C
14.3.1 Business Overview
14.3.2 Services Offered
14.3.3 Business Strategies
14.3.4 SWOT Analysis
14.3.5 Major News and Events
14.4 Company D
14.4.1 Business Overview
14.4.2 Services Offered
14.4.3 Business Strategies
14.4.4 SWOT Analysis
14.4.5 Major News and Events
14.5 Company E
14.5.1 Business Overview
14.5.2 Services Offered
14.5.3 Business Strategies
14.5.4 SWOT Analysis
14.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.
15 Japan Pharmacovigilance Market - Industry Analysis
15.1 Drivers, Restraints, and Opportunities
15.1.1 Overview
15.1.2 Drivers
15.1.3 Restraints
15.1.4 Opportunities
15.2 Porters Five Forces Analysis
15.2.1 Overview
15.2.2 Bargaining Power of Buyers
15.2.3 Bargaining Power of Suppliers
15.2.4 Degree of Competition
15.2.5 Threat of New Entrants
15.2.6 Threat of Substitutes
15.3 Value Chain Analysis
16 Appendix